Key facts
- Notable investors include Sage Growth Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Nova Vita Laboratories
- ·The full record, as it builds
Funding rounds
No funding rounds for Nova Vita Laboratories are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nova Vita Laboratories
Developer of regenerative medicine products designed for clinical and research applications in advanced therapeutics. The company's platform focuses on amniotic fluid-based products, adhering to regulatory standards for minimal manipulation and homologous use, enabling healthcare providers and researchers to access innovative therapies.
- Sector
- Healthcare
- HQ
- NC
- Founded
- 2023
- Employees
- 9
- Website
- novavitalabs.com/
- Ownership
- Privately Held (backing)
Nova Vita Laboratories doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nova Vita Laboratories shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nova Vita Laboratories in its N-PORT filings yet. We sweep new filings monthly.